senate Bill S1976B

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund

download pdf

Sponsor

Co-Sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 09 / Jan / 2013
    • REFERRED TO HEALTH
  • 22 / May / 2013
    • AMEND AND RECOMMIT TO HEALTH
  • 22 / May / 2013
    • PRINT NUMBER 1976A
  • 08 / Jan / 2014
    • REFERRED TO HEALTH
  • 10 / Feb / 2014
    • AMEND AND RECOMMIT TO HEALTH
  • 10 / Feb / 2014
    • PRINT NUMBER 1976B

Summary

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund; authorizes the commissioner of taxation and finance to create a check-off gift on individual income tax returns for contributions to leukemia, lymphoma and myeloma research, education and treatment.

do you support this bill?

Bill Details

See Assembly Version of this Bill:
A558B
Versions:
S1976
S1976A
S1976B
Legislative Cycle:
2013-2014
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add Art 27-CCC §2747, Pub Health L; add §§209-I & 630-d, Tax L; add §97-llll, St Fin L
Versions Introduced in Previous Legislative Cycles:
2011-2012: S569A, A283A
2009-2010: S1197A, A3075A
2007-2008: S3097B, A1558C

Sponsor Memo

BILL NUMBER:S1976B

TITLE OF BILL: An act to amend the public health law, the tax law and
the state finance law, in relation to providing for taxpayer gifts for
leukemia, lymphoma and myeloma research, education and treatment and
establishing the leukemia, lymphoma and myeloma research, education
and treatment fund

PURPOSE OR GENERAL IDEA OF BILL:

The purpose of this bill is to provide easy access to help fund and
support Leukemia, Lymphoma, and Myeloma research, education and
treatment.

SUMMARY OF SPECIFIC PROVISIONS:

Section 1 - Amends the public health law by adding a new article
27-CCC. The new article provides the Commissioner of Health with the
powers to: develop programs concerning Leukemia, Lymphoma, and
Myeloma, to accept and expend grants, awards and other funding, and to
enter into contracts necessary for program development and granting.
Section 2 - Amends the law by adding a new section 209-1. The new
section provides for the Commissioner of Taxation and Finance to
include a space on the corporate income tax return for contributions
to Leukemia, Lymphoma, and Myeloma research, education and treatment.
Section 3 - Amends part 2 of article 22 of the tax law by adding new
section 630-d. The new section provides for the Commissioner of
Taxation and Finance to include a space on the individual income tax
return for contributions to Leukemia, Lymphoma, and Myeloma research,
education and treatment. Section 4 - Amends the state finance law by
adding a new section 97-1111. The new section provides for the
establishment of a special fund, consisting of revenues received under
section 209-i and 630-d of the tax law and any other moneys
appropriated, credited or transferred, for Leukemia, Lymphoma and
Myeloma research, education and treatment. The custody of this fund
will be held jointly by the Commissioner of Taxation and Finance and
the Comptroller. Further, the new section provides that all monies in
the fund to be used only for Leukemia, Lymphoma and Myeloma research,
education and treatment programs approved by the Department of Health.
Additionally, the new section provides that the Comptroller must
approve releases of money that are certified by the Commissioner of
Health and that all money in the fund should be used prior to the end
of the fiscal year.

JUSTIFICATION:

Research and treatment efforts for many diseases, including
Alzheimer's and breast cancer, have benefited from additional funding
resulting from having a "check-off box" placed on the individual and
corporate income tax returns. Leukemia, Lymphoma and Myeloma are blood
cancers originating in the bone marrow and correlate with each other
because of the unrestrained growth of the cells and the parallel
functions which they possess. Leukemia, although more common in adults
over the age of 64, is still the leading cause of disease death of
children under 15 yrs old, with Acute Lymphocytic Leukemia (ALL) being
the most common form of Leukemia in children. Treatment advances for
Leukemia have proven to be prevalent in the survival rate over the


years, with the survival rate increasing from 4% in 1960 to 85% in
1999. Lymphoma involves two particular forms including Non-Hodgkin,
which is the fifth most common cancer in the U.S. and Hodgkin
Lymphoma, which mostly affects adolescents and young adults. Myeloma
occurs mostly in people over 60 yrs old with males having a 50% higher
chance than females of being diagnosed. Each year an estimated 106,200
people in the United States are diagnosed with Leukemia, Lymphoma, or
Myeloma. At the present time, an estimated 670,950 Americans have
blood cancers. Approximately 57,500 Americans will die from these
hematological malignancies this year. In New York State alone, there
are approximately 6,600 people diagnosed with a blood cancer each year
and 3,500 people will succumb to this disease.

PRIOR LEGISLATIVE HISTORY:

2012: A.0283-Passed Assembly S.0569- Died in Senate Health
2011: A.0283- Passed Assembly S.0569- Died in Senate Health
2010: A.3075- A Died on 3rd Rdg. S.1197-A - Died in Senate Health
2009: A.3075 Passed Assembly;
2008: A.1558-C Passed Assembly; S.3097-B Died in Senate Health
2007: A.1558-A Passed Assembly; S.3097-A-- Died in Senate Health
2006: A.3338-A Passed Assembly; S.2871-A-Died in Senate Health;
2005: A.3338-Passed Assembly; S.2878-A Died in Senate Health
2004: A.9816-Passed Assembly; S.6491-Died in Senate Health

FISCAL IMPLICATIONS:

Minimal to the state.

EFFECTIVE DATE:

This act shall apply to taxable years commencing on or after January
1, 2016.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 1976--B

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced by Sens. ROBACH, BRESLIN, MARCHIONE -- read twice and ordered
  printed,  and  when printed to be committed to the Committee on Health
  -- committee discharged, bill amended, ordered  reprinted  as  amended
  and  recommitted  to said committee -- recommitted to the Committee on
  Health  in  accordance  with  Senate  Rule  6,  sec.  8  --  committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma  and myeloma research, education and treatment and establishing the
  leukemia, lymphoma and myeloma research, education and treatment fund

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION 2747. LEUKEMIA, LYMPHOMA AND  MYELOMA  RESEARCH,  EDUCATION  AND
                TREATMENT.
  S  2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT.  THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A  PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA  AND  MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION, THE COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1. TO PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS  DESIGNED  TO
REDUCE  OR  PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA, LYMPHOMA AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS  AS

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00819-04-4

S. 1976--B                          2

TO  THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE FUNDS
BY THE STATE FINANCE LAW; AND
  3.  TO  ENTER  INTO CONTRACTS WITHIN THE AMOUNTS AVAILABLE THEREFOR AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
  S 2. The tax law is amended by adding a new section 209-I to  read  as
follows:
  S  209-I.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO  THOUSAND  SIXTEEN,  A TAXPAYER IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE SUPPORT OF THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION  SHALL  BE  IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED  BY  SUCH  TAXPAYER.  THE  COMMISSIONER  SHALL INCLUDE SPACE ON THE
CORPORATE INCOME TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIB-
UTION.   NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL  REVENUES
COLLECTED PURSUANT TO THIS SECTION SHALL BE CREDITED  TO  THE  LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED  ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF
THE STATE FINANCE LAW.
  S 3. The tax law is amended by adding a new section 630-d to  read  as
follows:
  S  630-D.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO THOUSAND SIXTEEN, AN INDIVIDUAL IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH,
EDUCATION  AND  TREATMENT  FUND. SUCH CONTRIBUTION SHALL BE IN ANY WHOLE
DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY  SUCH
INDIVIDUAL.  THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL INCOME
TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIBUTION.    NOTWITH-
STANDING  ANY  OTHER PROVISION OF LAW ALL REVENUES COLLECTED PURSUANT TO
THIS SECTION SHALL BE CREDITED TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
RESEARCH,  EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF THE STATE FINANCE LAW.
  S 4. The state finance law is amended by adding a new section  97-llll
to read as follows:
  S  97-LLLL.  LEUKEMIA,  LYMPHOMA  AND  MYELOMA RESEARCH, EDUCATION AND
TREATMENT FUND. 1. THERE IS HEREBY ESTABLISHED IN THE JOINT  CUSTODY  OF
THE  COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2. SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE  DEPARTMENT
OF  TAXATION  AND  FINANCE,  PURSUANT  TO  THE PROVISIONS OF SECTION TWO
HUNDRED NINE-I AND SECTION SIX HUNDRED THIRTY-D OF THE TAX LAW  AND  ALL
OTHER  MONEYS  APPROPRIATED,  CREDITED,  OR TRANSFERRED THERETO FROM ANY
OTHER FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS  SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3.  MONIES  OF  THE FUND SHALL BE EXPENDED ONLY FOR LEUKEMIA, LYMPHOMA
AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN  THIS
SECTION,  "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING GRANTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT,  WHICH,  PURSUANT TO SECTION TWENTY-SEVEN HUNDRED FORTY-SEVEN
OF THE PUBLIC HEALTH LAW, ARE APPROVED  BY  THE  DEPARTMENT  OF  HEALTH.

S. 1976--B                          3

SUCH  GRANTS  MAY  INCLUDE,  AMONG  OTHERS, GRANTS TO PUBLIC AND PRIVATE
HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
  4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
OF HEALTH.
  5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2016.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.